Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
The researchers found that women assigned to anastrozole were 50 percent less likely to have developed breast cancer.
Task force says some women can benefit from risk-reducing drugs like tamoxifen, but women at average risk should not take them.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.